Evidence map›Paper›PMID 33913051›Full record

ArticleInflammation2021

Anti-inflammatory Effects of Sweroside on LPS-Induced ALI in Mice Via Activating SIRT1.

Juan Wang, Xiaolan Cai, Rui Ma, Dapeng Lei, Xinliang Pan, Fengshan Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Frontiers in pharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Frontiers in oncology · 2024
    Review
  11. Article
  12. The Anti-Inflammatory Effects of Broccoli (Current issues in molecular biology · 2023
    Article
  13. Sweroside plays a role in mitigating high glucose-induced damage in human renal tubular epithelial HK-2 cells by regulating the SIRT1/NF-κB signaling pathway.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
  14. In Vitro and In Vivo Anti-Psoriasis Activity ofLife (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juan WangDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China. juan.wang@sdu.edu.cn.
Xiaolan CaiDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China.
Rui MaDepartment of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Dapeng LeiDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China.
Xinliang PanDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, China.
Fengshan WangInstitute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, China. fswang@sdu.edu.cn.ORCID http://orcid.org/0000-0002-3622-8432

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sweroside, as one of the main components of Swertia L. in Gentianaceae, has the effect of clearing heat and detoxifying. In previous studies, sweroside has been reported to have anti-inflammatory effect on LPS-induced inflammation by alleviating NF-κB signaling pathway. In this paper, we investigate the anti-inflammatory effects of sweroside by establishing LPS-induced acute lung injury (ALI) model in mice. Experimental results showed that sweroside could reduce the wet-to-dry ratio of the lung and inhibit MPO activity. In addition, it turned out that sweroside reduced pathological changes in lung tissue and the numbers of inflammatory cells. Moreover, sweroside significantly reduced the levels of inflammatory cytokines and down-regulated the NF-κB signaling pathway. And the results demonstrated that sweroside could increase the expression of SIRT1, and the protective effects of sweroside on LPS-induced ALI were reversed by SIRT1 inhibitor EX-527. In conclusion, sweroside can protect LPS-induced ALI mice through inhibiting inflammation.

Indexed as

Acute Lung InjuryAnimalsAnti-Inflammatory AgentsDose-Response Relationship, DrugInflammation MediatorsIridoid GlucosidesLipopolysaccharidesMacrophagesMiceMice, Inbred C57BLSirtuin 1Anti-Inflammatory AgentsInflammation MediatorsIridoid GlucosidesLipopolysaccharidesSirt1 protein, mouseSirtuin 1swerosideALIcytokineLPSsweroside

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.